Haymaker Acquisition Corp. III Announces Stockholder Approval Of Business Combination With Biote
Haymaker Acquisition Corp. III (NASDAQ:HYAC) ("Haymaker" or the "Company"), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously
Bloomberg Reported Late Sunday Hormone Therapy Firm Biote Said to Go Public Via Haymaker SPAC
https://www.bloomberg.com/news/articles/2021-12-13/hormone-therapy-firm-biote-said-to-go-public-via-haymaker-spac